Our findings showed the prognostic value of SLC1A5 in HCC and lower-grade glioma (LGG) and provided novel insights into the correlation of and mechanism active between SLC1A5 expression and tumor immunity. The gene discussed is SLC1A5; the disease is central nervous system cancer.